iRhythm Technologies (IRTC) Projected to Post Earnings on Thursday

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) will likely be issuing its Q1 2025 quarterly earnings data after the market closes on Thursday, May 1st. Analysts expect iRhythm Technologies to post earnings of ($0.89) per share and revenue of $153.39 million for the quarter.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.01 EPS for the quarter, topping analysts' consensus estimates of ($0.29) by $0.30. The firm had revenue of $164.33 million during the quarter, compared to analyst estimates of $158.30 million. iRhythm Technologies had a negative net margin of 19.14% and a negative return on equity of 118.83%. On average, analysts expect iRhythm Technologies to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

iRhythm Technologies Stock Up 3.2 %

Shares of iRhythm Technologies stock opened at $102.64 on Thursday. The company has a quick ratio of 6.12, a current ratio of 6.27 and a debt-to-equity ratio of 9.00. iRhythm Technologies has a twelve month low of $55.92 and a twelve month high of $128.52. The company has a market cap of $3.28 billion, a price-to-earnings ratio of -28.20 and a beta of 1.45. The company's 50 day moving average is $104.76 and its 200 day moving average is $93.96.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Needham & Company LLC raised their price target on iRhythm Technologies from $125.00 to $138.00 and gave the stock a "buy" rating in a research note on Friday, February 21st. Wells Fargo & Company raised their target price on iRhythm Technologies from $86.00 to $104.00 and gave the stock an "equal weight" rating in a research report on Friday, February 21st. Truist Financial upped their price target on shares of iRhythm Technologies from $111.00 to $145.00 and gave the company a "buy" rating in a research report on Friday, February 21st. The Goldman Sachs Group raised their price objective on shares of iRhythm Technologies from $91.00 to $124.00 and gave the stock a "neutral" rating in a report on Monday, February 24th. Finally, StockNews.com upgraded shares of iRhythm Technologies from a "sell" rating to a "hold" rating in a research report on Monday, February 24th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, iRhythm Technologies presently has an average rating of "Moderate Buy" and a consensus price target of $119.73.

iRhythm Technologies Company Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.